Report overview
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
This report contains market size and forecasts of Diabetes Injection Pens in global, including the following market information:
Global Diabetes Injection Pens Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Diabetes Injection Pens Market Sales, 2018-2023, 2023-2030, (M Units)
Global top five Diabetes Injection Pens companies in 2022 (%)
The global Diabetes Injection Pens market was valued at US$ 4408 million in 2022 and is projected to reach US$ 6532.5 million by 2030, at a CAGR of 5.8% during the forecast period 2023-2030.
Global diabetes injection pens key players include Novo Nordisk, Eli Lilly, Sanofi, BD, etc. Global top 1 manufacturer hold a share nearly 50%.
Europe is the largest market, with a share over 45%, followed by China and North America, both have a share about 35 percent.
In terms of product, reusable insulin pens is the largest segment, with a share over 80%. And in terms of application, the largest application is retail pharmacy, followed by hospital and clinic, online sales, etc.
We surveyed the Diabetes Injection Pens manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Injection Pens Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (M Units)
Global Diabetes Injection Pens Market Segment Percentages, by Type, 2022 (%)
Reusable Insulin Pens
Disposable Insulin Pens
Global Diabetes Injection Pens Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (M Units)
Global Diabetes Injection Pens Market Segment Percentages, by Application, 2022 (%)
Hospital & Clinic
Retail Pharmacy
Online Sales
Global Diabetes Injection Pens Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (M Units)
Global Diabetes Injection Pens Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Injection Pens revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Diabetes Injection Pens revenues share in global market, 2022 (%)
Key companies Diabetes Injection Pens sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Diabetes Injection Pens sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Delfu
